Current Value
$0.841 Year Return
Current Value
$0.841 Year Return
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| NTLA | 38.64% | $1.26B | -50.63% | 0.00% |
| VICR | 38.19% | $2.13B | +32.94% | 0.00% |
| OLED | 37.31% | $7.49B | -29.01% | 1.09% |
| KLIC | 36.62% | $1.95B | -28.42% | 2.22% |
| WNC | 36.52% | $467.69M | -48.69% | 2.92% |
| HCAT | 36.32% | $277.71M | -37.26% | 0.00% |
| SON | 35.86% | $4.64B | -5.24% | 4.48% |
| AVT | 35.70% | $4.72B | +6.57% | 2.37% |
| CSGP | 35.70% | $36.30B | +14.43% | 0.00% |
| CTS | 35.67% | $1.28B | -17.53% | 0.38% |
| RXRX | 35.63% | $2.47B | -25.59% | 0.00% |
| BLFS | 35.62% | $1.09B | +8.35% | 0.00% |
| GPRO | 35.51% | $129.03M | -50.06% | 0.00% |
| COHU | 35.39% | $957.96M | -41.53% | 0.00% |
| VECO | 35.24% | $1.28B | -54.31% | 0.00% |
| SLAB | 34.75% | $4.65B | +20.25% | 0.00% |
| HLNE | 34.63% | $6.34B | +13.71% | 1.33% |
| LSCC | 34.21% | $7.55B | -6.43% | 0.00% |
| BHE | 34.20% | $1.46B | +0.80% | 1.70% |
| BEAM | 34.05% | $2.22B | -14.88% | 0.00% |
Finnhub
Immunic Therapeutics Developing Selective Oral Therapies in Immunology NASDAQ: IMUX | July 2025 ...
Yahoo
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today reported new long-term open-label extension (OLE) data from its phase 2 EMPhASIS trial of lead asset, orally available nuclear receptor-related 1 (Nurr1) activator, vidofludimus calcium (IMU-838), in patients with relapsing-remitting multiple sclerosis (RRMS).
Finnhub
Immunic, Inc. reported new long-term open-label extension data from its phase 2 EMPhASIS trial of lead asset, orally available nuclear receptor-related 1 activator, vidofludimus calcium , in...
SeekingAlpha
IMUX stock's drop appears to be an overreaction, given positive disability progression data and clean safety profile. Click to read why IMUX is a Strong Buy.
Yahoo
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced the completion of enrollment for both phase 3 ENSURE trials of lead asset, nuclear receptor-related 1 (Nurr1) activator, vidofludimus calcium (IMU-838), in patients with relapsing multiple sclerosis and additional phase 2 CALLIPER trial data in patients with progressive multiple sclerosis underlining the
Finnhub
Immunic Therapeutics Developing Selective Oral Therapies in Immunology NASDAQ: IMUX | June 2025 ...
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| AWK | 0.02% | $27.82B | +4.74% | 2.18% |
| HRTG | 0.03% | $661.40M | +211.08% | 0.00% |
| ICFI | 0.05% | $1.65B | -31.69% | 0.63% |
| FDP | 0.14% | $1.61B | +52.20% | 3.28% |
| PEP | -0.14% | $186.58B | -17.00% | 4.07% |
| VZ | -0.21% | $177.21B | +1.77% | 8.05% |
| PRA | -0.26% | $1.22B | +106.78% | 0.00% |
| KDP | -0.29% | $45.70B | +3.76% | 2.75% |
| BBW | 0.32% | $678.92M | +102.92% | 1.64% |
| LFVN | -0.34% | $155.72M | +105.82% | 1.34% |
| LVO | -0.36% | $73.99M | -46.53% | 0.00% |
| CAG | -0.38% | $9.30B | -31.32% | 7.20% |
| COCO | 0.44% | $2.11B | +22.26% | 0.00% |
| NPWR | 0.45% | $258.83M | -63.80% | 0.00% |
| NEUE | -0.47% | $60.71M | +34.39% | 0.00% |
| AFL | 0.49% | $55.30B | +10.67% | 2.13% |
| NHI | 0.51% | $3.32B | -1.17% | 5.10% |
| AEM | -0.52% | $59.73B | +58.34% | 1.35% |
| SBS | 0.54% | $13.75B | +30.48% | 3.28% |
| AGI | -0.54% | $10.98B | +49.03% | 0.38% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CME | -17.22% | $99.17B | +44.04% | 1.75% |
| CBOE | -16.96% | $24.55B | +38.09% | 1.08% |
| PPC | -12.18% | $10.64B | +33.60% | 0.00% |
| EZPW | -11.87% | $760.29M | +36.43% | 0.00% |
| RYAN | -11.67% | $8.19B | +14.73% | 0.71% |
| COR | -11.09% | $57.63B | +33.93% | 0.73% |
| KR | -10.93% | $46.75B | +34.05% | 1.81% |
| EXC | -9.79% | $44.05B | +23.53% | 3.60% |
| RCKY | -9.68% | $181.75M | -28.16% | 2.57% |
| CHD | -9.57% | $24.40B | -4.48% | 1.17% |
| ED | -9.48% | $36.42B | +10.51% | 3.36% |
| LITB | -9.21% | $24.26M | -71.62% | 0.00% |
| CCEC | -9.08% | $1.02B | +3.91% | 2.48% |
| MCK | -8.84% | $89.25B | +24.22% | 0.40% |
| PGR | -8.75% | $146.19B | +17.73% | 1.98% |
| MO | -8.66% | $98.62B | +24.36% | 7.00% |
| CIG.C | -8.64% | $2.68B | +23.72% | 0.00% |
| PSQH | -8.58% | $105.65M | -40.36% | 0.00% |
| VTR | -8.11% | $28.56B | +19.44% | 2.95% |
| MOH | -8.09% | $12.39B | -21.20% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| ARKG | 41.16% | $1.03B | 0.75% |
| GNOM | 39.04% | $46.47M | 0.5% |
| QCLN | 38.70% | $415.53M | 0.56% |
| IWC | 38.04% | $840.86M | 0.6% |
| PBW | 38.01% | $294.50M | 0.65% |
| XBI | 37.49% | $4.81B | 0.35% |
| ICVT | 37.39% | $2.67B | 0.2% |
| KOMP | 36.77% | $2.34B | 0.2% |
| ACES | 36.60% | $97.20M | 0.55% |
| ULTY | 36.53% | $961.00M | 1.3% |
| IWO | 36.32% | $11.77B | 0.24% |
| CWB | 36.27% | $3.91B | 0.4% |
| IWM | 35.31% | $65.64B | 0.19% |
| GSSC | 35.27% | $591.16M | 0.2% |
| BUZZ | 35.27% | $69.55M | 0.76% |
| VTWO | 35.23% | $12.65B | 0.07% |
| IWMY | 35.12% | $120.43M | 1.02% |
| PBD | 34.66% | $75.55M | 0.75% |
| SPHB | 34.55% | $423.06M | 0.25% |
| METV | 34.52% | $301.64M | 0.59% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -30.84% | $315.93M | 1.43% |
| VIXY | -27.89% | $184.73M | 0.85% |
| TAIL | -25.81% | $94.86M | 0.59% |
| IVOL | -17.02% | $342.69M | 1.02% |
| XONE | -15.20% | $628.85M | 0.03% |
| XHLF | -14.20% | $1.73B | 0.03% |
| UTWO | -14.01% | $376.33M | 0.15% |
| BILS | -13.23% | $3.80B | 0.1356% |
| SPTS | -12.15% | $5.77B | 0.03% |
| WEAT | -11.54% | $123.28M | 0.28% |
| STPZ | -11.00% | $443.27M | 0.2% |
| IBTG | -10.26% | $1.92B | 0.07% |
| LDUR | -10.19% | $922.12M | 0.5% |
| FTSM | -9.98% | $6.34B | 0.45% |
| IBTH | -9.57% | $1.62B | 0.07% |
| VGSH | -9.24% | $22.68B | 0.03% |
| SHY | -8.55% | $23.54B | 0.15% |
| YEAR | -8.23% | $1.46B | 0.25% |
| CORN | -7.74% | $43.71M | 0.2% |
| SCHO | -7.27% | $10.98B | 0.03% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BNDX | 0.01% | $67.46B | 0.07% |
| FLGV | 0.15% | $1.02B | 0.09% |
| SHAG | -0.30% | $42.91M | 0.12% |
| DFNM | -0.30% | $1.58B | 0.17% |
| IBTP | -0.37% | $142.98M | 0.07% |
| UTEN | 0.39% | $210.57M | 0.15% |
| GSST | -0.40% | $920.88M | 0.16% |
| GVI | 0.43% | $3.44B | 0.2% |
| FLIA | 0.48% | $706.55M | 0.25% |
| BSMR | -0.57% | $258.51M | 0.18% |
| CCOR | -0.67% | $51.03M | 1.18% |
| FXC | -0.84% | $92.85M | 0.4% |
| SHYM | 0.84% | $355.86M | 0.35% |
| USDU | -0.85% | $129.80M | 0.5% |
| SOYB | -0.87% | $26.47M | 0.22% |
| DBA | 0.88% | $768.97M | 0.93% |
| IGOV | 0.90% | $1.23B | 0.35% |
| TIPX | -0.91% | $1.73B | 0.15% |
| OWNS | 1.01% | $128.37M | 0.3% |
| CGSM | 1.07% | $716.74M | 0.25% |
